Endocannabinoids in the Islets of Langerhans: the ugly, the bad, and the good facts.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

1. Acute metabolic effects of cannabinoid receptor modulators during sequential hyperglycemic, euglycemic-hyperinsulinemic clamps in healthy individuals.American journal of physiology. Endocrinology and metabolism · 2026
   Trial
2. Developmental programming: Testosterone excess masculinizes female pancreatic transcriptome and function in sheep.Molecular and cellular endocrinology · 2024
   Article
3. Endocrinology of Taste with Aging.Endocrinology and metabolism clinics of North America · 2023
   Review
4. Chronic marijuana usage by human pancreas donors is associated with impaired islet function.PloS one · 2021
   Article
5. Cannabinoid receptors are differentially regulated in the pancreatic islets during the early development of metabolic syndrome.Islets · 2020
   Article
6. Anti-obesity therapy with peripheral CB1 blockers: from promise to safe(?) practice.International journal of obesity (2005) · 2020
   Review
7. A Guide to Targeting the Endocannabinoid System in Drug Design.International journal of molecular sciences · 2020
   Review
8. The Expanded Endocannabinoid System/Endocannabinoidome as a Potential Target for Treating Diabetes Mellitus.Current diabetes reports · 2019
   Review
9. Age-Related Changes in Glucose Metabolism, Hyperglycemia, and Cardiovascular Risk.Circulation research · 2018
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 2 institutions in 1 country.

Funding

Abstract

Indexed as